News Outlet Provides Q&A On Zika Vaccine Research

Associated Press: Shots for other viruses offer clues in race for Zika vaccine
“Scientists are racing to create a Zika vaccine, and while they’re starting from scratch against a poorly understood disease, copying shots for similar viruses offers a head start. A variety of potential candidates are being pursued: Simple DNA vaccines, made with only a few genes from the virus; some made from killed or inactivated virus, much like a standard flu shot; others made with live but weakened virus…” (Neergaard, 3/14).

The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.

The Henry J. Kaiser Family Foundation Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270

www.kff.org | Email Alerts: kff.org/email | facebook.com/KaiserFamilyFoundation | twitter.com/kff

Filling the need for trusted information on national health issues, the Kaiser Family Foundation is a nonprofit organization based in San Francisco, California.